VRTX
Vertex Pharmaceuticals Incorporated
NASDAQ · Healthcare · Biotechnology · US
$546.12
−2.12%0
Insider buys (3m)
7
Insider sells (3m)
-$5.4M
Net value (3m)
+23.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 1, 2026 | Ambrose Kristen · officer: SVP & Chief Accounting Officer | A-Award | 5,000 | $0.00 |
| Jul 23, 2026 | Tatsis Ourania · officer: EVP, Chief Reg. & Quality Off. | A-Award | 8,251 | $0.00 |
| Jul 23, 2026 | Sachdev Amit · officer: EVP Chief Patient & Ext Af Off | A-Award | 8,251 | $0.00 |
| Jul 17, 2026 | Garber Alan M · director | A-Award | 32 | $0.00 |
| Jul 17, 2026 | SACHS BRUCE I · director | A-Award | 100 | $0.00 |
| Jul 7, 2026 | Tatsis Ourania · officer: EVP, Chief Reg. & Quality Off. | Sale | 1,500 | $525 |
| Jul 7, 2026 | McKechnie Duncan · officer: EVP, Chief Commercial Officer | Sale | 1,541 | $519 |
| Jul 6, 2026 | Liu Joy · officer: EVP and Chief Legal Officer | Sale | 828 | $503 |
| Jun 30, 2026 | Bozic Carmen · officer: EVP and CMO | Sale | 596 | $483 |
| Jun 23, 2026 | Bozic Carmen · officer: EVP and CMO | Sale | 1,020 | $462 |
| Jun 17, 2026 | Bozic Carmen · officer: EVP and CMO | Sale | 4,062 | $450 |
| Jun 9, 2026 | Bozic Carmen · officer: EVP and CMO | Sale | 1,745 | $450 |
| Jun 2, 2026 | Bozic Carmen · officer: EVP and CMO | Sale | 1,974 | $450 |
| May 19, 2026 | Bunnage Mark E. · officer: EVP, Chief Scientific Officer | Sale | 33 | $453 |
| May 19, 2026 | Bozic Carmen · officer: EVP and CMO | Sale | 1,354 | $453 |
| May 14, 2026 | Bozic Carmen · officer: EVP and CMO | Sale | 6,988 | $450 |
| May 5, 2026 | Bhatia Sangeeta N. · director | A-Award | 943 | $0.00 |
| May 5, 2026 | Liu Joy · officer: EVP and Chief Legal Officer | Sale | 1,104 | $425 |
| May 5, 2026 | Thornberry Nancy · director | A-Award | 1,433 | $424 |
| May 5, 2026 | Schneider Jennifer · director | A-Award | 1,433 | $424 |
| May 5, 2026 | MCKENZIE DIANA · director | A-Award | 943 | $0.00 |
| May 5, 2026 | Thornberry Nancy · director | A-Award | 472 | $0.00 |
| May 5, 2026 | Upadhyay Suketu · director | A-Award | 2,866 | $424 |
| May 5, 2026 | MCKENZIE DIANA · director | A-Award | 796 | $0.00 |
| May 5, 2026 | Bhatia Sangeeta N. · director | Sale | 318 | $424 |
| May 5, 2026 | Schneider Jennifer · director | A-Award | 796 | $0.00 |
| May 5, 2026 | Garber Alan M · director | A-Award | 472 | $0.00 |
| May 5, 2026 | Garber Alan M · director | A-Award | 1,433 | $424 |
| May 5, 2026 | Upadhyay Suketu · director | A-Award | 796 | $0.00 |
| May 5, 2026 | CARNEY LLOYD · director | A-Award | 2,866 | $424 |
Institutional positioning
13F filings over the trailing two quarters
New 352Increased 1381Reduced 1242Sold out 115
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Capital World Investors | Increased | 26,115,014 | Aug 12, 2026 |
| CAPITAL WORLD INVESTORS | Reduced | 25,368,124 | May 13, 2026 |
| BlackRock, Inc. | Increased | 24,109,373 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 23,969,517 | May 13, 2026 |
| CAPITAL RESEARCH GLOBAL INVESTORS | Increased | 21,125,964 | May 13, 2026 |
| Capital Research Global Investors | Reduced | 19,490,637 | Aug 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 16,580,713 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 16,512,810 | May 15, 2026 |
| STATE STREET CORP | Increased | 11,871,459 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 11,730,139 | May 15, 2026 |
| Invesco Ltd. | Increased | 8,043,052 | Aug 14, 2026 |
| JPMORGAN CHASE & CO | Increased | 7,033,156 | May 13, 2026 |
| JPMORGAN CHASE & CO | Reduced | 6,517,600 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 6,139,621 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 6,017,848 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 1, 2026